IntegraFin Holdings plc (IHP)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 368.00 |
|---|---|
| 52-week range | 289.79 – 402.00 |
| Return, 1 month / 3 months | −0.8% / −6.1% |
| Return, 1 year / 3 years | +5.7% / +85.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 25.3% |
| Worst drawdown (1 year) | -18.8% |
| Average daily value traded | 211.35M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
IntegraFin Holdings plc is the parent company of Transact, an investment platform serving financial advisers in the United Kingdom. Through Transact, advisers manage their clients' investments and tax wrappers, including individual savings accounts and pensions, on a single integrated system. The platform handles administration, record keeping and reporting for those adviser-managed portfolios. IntegraFin is based in London and earns its revenue mainly from fees charged on the assets held by clients on the platform.
On this site IntegraFin Holdings plc appears as a stock on the London Exchange (UK), code IHP, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
IntegraFin Holdings plc (IHP) trades on the London Exchange in UK. It last closed at GBX 368.00 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 678 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.7% and over the last three months it fell 6.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.1% | ||
| From 52-week high | -7.9% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.1% | ||
| 6-month return | 6.9% | ||
| 12-month return, skipping the last month | 6.6% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.8% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 211.35M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −0.8% |
| 3 months | −6.1% |
| 6 months | +6.9% |
| 1 year | +5.7% |
| 3 years | +85.9% |
| 5 years | −25.0% |
Signals
| 50-day / 200-day average | 378.23 / 350.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | GBP 0.0380 |
| 2 Jan 2026 | GBP 0.0800 |
| 5 Jun 2025 | GBP 0.0330 |
| 2 Jan 2025 | GBP 0.0720 |
| 6 Jun 2024 | GBP 0.0320 |
| 21 Dec 2023 | GBP 0.0700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.